Insiders · Profile

Bohen Sean

PRESIDENT AND CEO at Olema Pharmaceuticals. Filing since 1 Sep 2021. CIK 0001831218

Company
Date
Role
Action
Shares
Amount
Of holding
11 Dec 2024
PRESIDENT AND CEO
Sold at will
57,174
$496.05K
19.1%
10 Dec 2024
PRESIDENT AND CEO
Sold at will
52,328
$490.31K
14.9%
22 Nov 2023
PRESIDENT AND CEO
Sold at will
27,932
$388.25K
16.2%
21 Nov 2023
PRESIDENT AND CEO
Sold at will
29,293
$435.88K
14.5%
14 Oct 2021
PRESIDENT AND CEO
Sold, plan not stated
5,000
$152.36K
8.7%
27 Sep 2021
PRESIDENT AND CEO
Sold, plan not stated
1,085
$32.63K
2.0%
8 Sep 2021
PRESIDENT AND CEO
Sold, plan not stated
2,631
$78.93K
4.8%
7 Sep 2021
PRESIDENT AND CEO
Sold, plan not stated
413
$12.42K
0.8%
1 Sep 2021
PRESIDENT AND CEO
Sold, plan not stated
871
$26.17K
1.6%
9 decisions on file.